LIWANLI Innovation Co Ltd (3054)

Currency in TWD
25.20
+1.20(+5.00%)
Closed·
3054 Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
3054 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
24.0026.00
52 wk Range
18.6027.25
Key Statistics
Bid/Ask
22.20 / 22.60
Prev. Close
23.4
Open
24
Day's Range
24-26
52 wk Range
18.6-27.25
Volume
16.88K
Average Volume (3m)
11.09K
1-Year Change
23.83%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
3054 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
RSI suggests the stock is in overbought territory

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy

LIWANLI Innovation Co Ltd Company Profile

LIWANLI Innovation Co., Ltd. operates in the biomedical science industry in Taiwan and internationally. The company offers Vigoway and powder collection products for male, female, elderly, and children. Its products include anti-aging desire, pro-active nutrients capsules, black elderberry powder, probiotic enzymes, oral care tablets, resveratrol red grape extract, algae DHA soft gels, shea butter with type II collagen soft gels, algae astaxanthin sQ10 soft gels, cordyceps militaries powder, tooth guard tablets, bovine and goat’s milk bites, bilberry-tablets, DHA and vitamin D3 drops, and other products. In addition, the company provides products in the areas of nutrition and healthcare. The company was formerly known as Carry Technology International Co., Ltd. and changed its name to LIWANLI Innovation Co., Ltd. in 2015. LIWANLI Innovation Co., Ltd. was founded in 1980 and is based in New Taipei City, Taiwan.

Compare 3054 to Peers and Sector

Metrics to compare
3054
Peers
Sector
Relationship
P/E Ratio
−78.6x−15.1x11.8x
PEG Ratio
0.32−0.690.01
Price/Book
2.7x2.1x2.4x
Price / LTM Sales
22.3x1.5x2.2x
Upside (Analyst Target)
-0.0%19.3%
Fair Value Upside
Unlock−15.4%4.6%Unlock

Earnings

Latest Release
Jul 29, 2025
EPS / Forecast
0.02 / --
Revenue / Forecast
31.92M / --
EPS Revisions
Last 90 days

3054 Income Statement

FAQ

What Stock Exchange Does LIWANLI Trade On?

LIWANLI is listed and trades on the Taiwan Stock Exchange stock exchange.

What Is the Stock Symbol for LIWANLI?

The stock symbol for LIWANLI is "3054."

What Is the LIWANLI Market Cap?

As of today, LIWANLI market cap is 2.03B.

What Is LIWANLI's Earnings Per Share (TTM)?

The LIWANLI EPS (TTM) is -0.32.

From a Technical Analysis Perspective, Is 3054 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has LIWANLI Stock Split?

LIWANLI has split 7 times.

How Many Employees Does LIWANLI Have?

LIWANLI has 0 employees.

What is the current trading status of LIWANLI (3054)?

As of 17 Aug 2025, LIWANLI (3054) is trading at a price of 25.20, with a previous close of 23.40. The stock has fluctuated within a day range of 24.00 to 26.00, while its 52-week range spans from 18.60 to 27.25.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.